ARCA biopharma Announces Completion of Enrollment in Phase 2b ASPEN-COVID-19 Clinical Trial Evaluating rNAPc2 as a Potential Treatment for Patients Hospitalized with COVID-19 Posted on December 2, 2021 by ARCA IT - Press Release, Uncategorized 12.2-ASPEN-COVID-19-trial-enrollment-completion
ARCA biopharma to Present at the Q4 Virtual Investor Summit on November 17th Posted on November 9, 2021 by ARCA IT - Press Release, Uncategorized 11.9-Q4-Virtual-Investor-Summit-Annc-FINAL
ARCA biopharma Announces Third Quarter 2021 Financial Results and Provides Corporate Update Posted on November 2, 2021 by ARCA IT - Press Release, Uncategorized 11.2-3Q2021-Financial-Results-and-Business-Update
ASPEN-COVID-19 Data and Safety Monitoring Committee Recommends Continuing Phase 2b Clinical Trial to Completion Based on Interim Analysis of Efficacy and Safety Data Posted on October 28, 2021 by ARCA IT - Press Release, Uncategorized 10.28-ASPEN-COVID-trial-interim-analysis-FINAL
ARCA biopharma Announces Enrollment of First International Patient in Phase 2b Clinical Trial Evaluating rNAPc2 as a Potential Treatment for COVID-19 Posted on September 16, 2021 by ARCA IT - Press Release, Uncategorized 9.16-rNAPc2-ASPEN-COVID-South-America-FPE
ARCA biopharma to Present at the Q3 Virtual Investor Summit on August 18th Posted on August 16, 2021 by ARCA IT - Press Release, Uncategorized 8.16-Q3-Virtual-Investor-Summit-Annc
ARCA biopharma Announces Submission of PCT Patent Application for the Treatment of Coronavirus Infection and Associated Coagulopathy with rNAPc2 Posted on August 9, 2021 by ARCA IT - Press Release, Uncategorized 8.9-rNAPc2-COVID-19-Patent-submission-FINAL
ARCA biopharma Announces Second Quarter 2021 Financial Results and Provides Corporate Update Posted on August 4, 2021 by ARCA IT - Press Release, Uncategorized 8.4-2Q2021-Financial-Results-and-Business-Update
Gencaro Atrial Fibrillation Phase 2B Results Selected for Publication in Circulation: Arrhythmia and Electrophysiology Posted on July 28, 2021 by ARCA IT - Press Release, Uncategorized 7.28-Gencaro-Data-Published-in-Circulation-A-and-E
ARCA biopharma Provides Update on ASPEN-COVID-19 Phase 2b Clinical Trial Evaluating rNAPc2 as a Potential Treatment for COVID-19 Posted on July 13, 2021 by ARCA IT - Press Release, Uncategorized 7.13-rNAPc2-ASPEN-COVID-Trial-Update